News

March 30, 2011 – Interventional radiologists have completed the first human randomized controlled trial of therapeutic renal denervation, or RDN. RDN is a procedure that uses a catheter-based probe inserted into the renal artery that emits high-frequency energy to deactivate the nerves near the kidneys (or in the renal artery) that are linked to high blood pressure.

Home March 30, 2011
Home
News

March 30, 2011 – Understanding that angioplasty is safe may encourage additional studies for its use as a treatment option for individuals with multiple sclerosis, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago.

Home March 30, 2011
Home
Technology

March 29, 2011 – The U.S. Food and Drug Administration (FDA) cleared a wireless point-of-care testing system that allows real time transmission of diagnostic test results generated directly from the patient bedside.

Home March 29, 2011
Home
News

March 29, 2011 – One-year outcomes from Cohort A of the PARTNER trial will be presented April 3 at the American College of Cardiology’s (ACC) 60th Annual Scientific Session and Expo in New Orleans. Additionally, economic data from Cohort B will be featured in a session immediately after.

Home March 29, 2011
Home
Feature

Wide beam reconstruction (WBR) reduces both dose and image acquisition time by 50 percent for myocardial perfusion SPECT (MPI), according to a new study published in the March-April 2011 issue of the Journal of Nuclear Cardiology. WBR is a software program by UltraSPECT for reconstructing nuclear medicine images.

Home March 29, 2011
Home
News

March 28, 2011- Terumo Medical Corp., a U.S.-based subsidiary of Japan-based Terumo Corp., expressed its condolences and support to its Japanese colleagues and others who are managing the extremely difficult situation resulting

Home March 29, 2011
Home
News

March 28, 2011 – Outcomes data from a subset analysis of the global e-HEALING registry were published online in the Journal of Interventional Cardiology and demonstrated the effectiveness of a stent in diabetic patients. The Genous Stent, from OrbusNeich, showed low definite and probable stent thrombosis (ST) comparable to non-diabetics.

Home March 28, 2011
Home
News

March 28, 2011 – The Therapeutic Goods Administration (TGA) of Australia has approved the HeartWare Ventricular Assist System for listing on the Australian Register of Therapeutic Goods (ARTG).

Home March 28, 2011
Home
News

March 28, 2011 – Patients who have suffered a "mini stroke" are at twice the risk of heart attack than the general population, according to research reported in Stroke: Journal of the American Heart Association.

Home March 28, 2011
Home
Technology

March 28, 2011 – The U.S. Food and Drug Administration (FDA) has approved two new cardiac resynchronization therapy-pacemaker (CRT-P) systems. The Consulta and Syncra CRT-P systems, from Medtronic, are the first to include OptiVol Fluid Status Monitoring. The feature identifies patients at risk for worsening heart failure before symptoms develop.

Home March 28, 2011
Home
News

March 28, 2011 – The Society of Nuclear Medicine’s (SNM) 2011 Annual Meeting, June 4-8 in San Antonio, offers a variety of new education options to nuclear medicine and molecular imaging professionals. With new topics, formats and technologies, the meeting provides a comprehensive review of the latest research and issues in the field.

Home March 28, 2011
Home
Technology

Horizon Cardiology, a cardiovascular information system (CVIS) from McKesson, is a comprehensive information solution from fetal to adult (including congenital) that supports cardiac and peripheral catheterization, hemodynamic monitoring, echocardiography, vascular ultrasound, nuclear cardiology and electrocardiogram (ECG) management.

Home March 25, 2011
Home
Technology

Horizon Cardiology, a cardiovascular information system (CVIS) from McKesson, is a comprehensive information solution from fetal to adult (including congenital) that supports cardiac and peripheral catheterization, hemodynamic monitoring, echocardiography, vascular ultrasound, nuclear cardiology and electrocardiogram (ECG) management.

Home March 25, 2011
Home
News

March 25, 2011 –At Jersey Shore University Medical Center, 66-year-old heart attack survivor Charles Theodora from Ocean Township became the first N.Y./N.J. metropolitan resident to be implanted with an experimental cardiac monitor system. The AngelMed Guardian cardiac monitor and alert system, by Angel Medical Systems, can alert Theodora if a heart attack is imminent.

Home March 25, 2011
Home
Technology

March 25, 2011 – A new galectin-3 test, recently cleared by the U.S. Food and Drug Administration (FDA) to help assess the prognosis of patients with chronic heart failure, is now offered by Health Diagnostic Laboratory (HDL). BG Medicine Inc. announced the agreement under which HDL will offer galectin-3 testing services based on the BG Medicine Galectin-3 Test.

Home March 25, 2011
Home
Subscribe Now